GlassScriptPhysician profile
Laura Riley
NPI 1659725083
$1,491.67
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $186 · 2021: $700 · 2022: $525 · 2023: $62.17 · 2024: $18.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.29 | 2021-2023 | Vraylar |
| Novo Nordisk INC | $191.83 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $144.97 | 2021 | |
| Glaxosmithkline, LLC. | $110.40 | 2020-2024 | Shingrix, Arexvy |
| Lilly USA, LLC | $104.09 | 2020-2023 | Mounjaro |
| Astellas Pharma US INC | $99.99 | 2022 | |
| Sanofi-Aventis U.S. LLC | $80.60 | 2020-2022 | |
| Pfizer INC. | $79.70 | 2021-2022 | |
| Amgen INC. | $71.60 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $54.84 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.96 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.75 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $28.57 | 2021 | |
| Jazz Pharmaceuticals INC. | $21.43 | 2021 | |
| Eisai INC. | $19.28 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.06 | 2022 | |
| Amarin Pharma, INC. | $18.83 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $17.47 | 2021 | |
| Mylan Specialty L.P. | $15.30 | 2022 | |
| Upsher-Smith Laboratories LLC | $14.26 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.20 | 2020 | |
| Sanofi Pasteur INC. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.